Salonga, D; Danenberg, K D; Johnson, M et al. (2000) Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 6:1322-7
|
Lehman, N L; Danenberg, P V (2000) Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy. Cancer Chemother Pharmacol 45:142-8
|
Ju, J; Kane, S E; Lenz, H J et al. (1998) Desensitization and sensitization of cells to fluoropyrimidines with different antisenses directed against thymidylate synthase messenger RNA. Clin Cancer Res 4:2229-36
|
Ju, J F; Banerjee, D; Lenz, H J et al. (1998) Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity. Clin Cancer Res 4:1315-22
|
Metzger, R; Danenberg, K; Leichman, C G et al. (1998) High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clin Cancer Res 4:2371-6
|
Fisher, A M; Danenberg, K; Banerjee, D et al. (1997) Increased photosensitivity in HL60 cells expressing wild-type p53. Photochem Photobiol 66:265-70
|
Formenti, S C; Dunnington, G; Uzieli, B et al. (1997) Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-fluorouracil and radiation therapy. Int J Radiat Oncol Biol Phys 39:1059-68
|
Skinner, K A; Dunnington, G; Silberman, H et al. (1997) Preoperative 5-fluorouracil and radiation therapy for locally advanced breast cancer. Am J Surg 174:705-7; discussion 707-8
|